Exploring the links between sleep hygiene, muscle loss, and brain function in lung disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how sleep hygiene affects the development of sarcopenia and cognitive dysfunction in patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). It focuses on various sleep indicators such as sleep duration, arousal, and quality to understand their impact on disease progression and overall prognosis. By clarifying these relationships, the study aims to provide insights into the management of sleep-related disorders in these patient populations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects with COPD or IPF.

Exclusion Criteria:

* Subjects who have been hospitalized for exacerbation of respiratory failure within 1 month of study participation
* Subjects who have already been diagnosed with sarcopenia or cognitive dysfunction
* Subjects receiving long-term oxygen therapy (LTOT) or non-invasive ventilation therapy (NIV)
* Subjects with obstructive sleep apnea who are indicated for continuous positive airway pressure (CPAP)
* Subjects with severe complications such as cardiovascular disease, liver disease, renal disease, malignancy, and neurological disease.

Where it's running

• National Hospital Organization Minami Kyoto Hospital
  Jōyō, Kyoto, Japan Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multidisciplinary sarcopenia clinic to diagnose and treat muscle loss from COPD

  This project will try a multidisciplinary sarcopenia clinic to see if it improves muscle mass, function, and overall health for COPD patients with CT-confirmed muscle loss after a hospitalization.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07059637

• Muscle loss in pregnant women with gestational diabetes.

  This project will test whether pregnant women with gestational diabetes show signs of muscle loss (sarcopenia) and whether those muscle measures relate to pregnancy outcomes and thinking skills.

  Recruiting at 2 sites Istituto di Neuroscienze Consiglio Nazionale delle Ricerche · Vienna and 2 other locations · NCT06876090

• Understanding muscle loss in patients with chronic lung diseases

  This study looks at how muscle loss affects people with chronic lung diseases like COPD and ILD to see how common it is and how it relates to their overall health.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT06280443

• Evaluating dietary supplements and exercise for patients with sarcopenia and lung disease

  This study is testing whether a combination of dietary supplements and supervised exercise can help people with sarcopenia and lung diseases like COPD and ILD improve their physical performance and lung function.

  Recruiting Orient Europharma Co., Ltd. · Taichung · NCT05926713

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.